FREE PDF: The Gospel According to GLP-1s: Less Appetite, More Indulgence

The dominant narrative around GLP-1 medications has been one of subtraction. Reduced appetite and consumption are the defining effects of GLP-1s. Yet, the research tells a more complicated story, where less consumption does not equate to less opportunity. 

Innova Market Insights’ latest Food for Thought article reveals that a meaningful and growing share of GLP-1 users say they are treating themselves more to indulgent foods since starting the medication. While consumers may be eating less, they are becoming more intentional, raising the bar for what makes an indulgence truly worthwhile.   

Reach out for the FREE PDF to discover what Innova’s consumer research indicates about how brands should approach new product development in the era of weight loss medications.